Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Sep 12, 2011, 05:46 ET from Reportlinker

NEW YORK, Sept. 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0611603/Orthobiologics---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial

Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information on the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Bone Allografts, Bone Graft Substitutes, Bone Growth Stimulators, DBM and Viscosupplementation.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within orthobiologics market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Medtronic, Genzyme Corporation, DePuy and Synthes.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the orthobiologics market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the orthobiologics market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global orthobiologics market and the factors shaping it.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction and Overview 8

2.1 Introduction 8

2.2 GlobalData Report Guidance 8

3 Orthobiologics - Device Overview 9

3.1 Orthobiologics Market - Market Segmentation 9

3.1.1 Bone Allografts 9

3.1.2 Bone Graft Substitutes 10

3.1.3 Bone Growth Stimulators 11

3.1.4 Viscosupplementation 12

3.2 Applications 12

3.2.1 Foot and Ankle Surgery 12

3.2.2 Spinal Fusion 13

3.2.3 Knee Surgery 13

3.2.4 Shoulder Surgery 13

3.2.5 Hip Surgery 13

3.2.6 Fractures and Bone Injuries 13

3.2.7 Bone Tumors 14

4 Orthobiologics Market - Global Market Characterization 15

4.1 Orthobiologics Market, Global, Revenue ($bn), Historic, 2003 - 2010 15

4.2 Orthobiologics Market, Global, Revenue ($bn), Forecast, 2010 - 2017 16

4.3 Global Orthobiologics Market, Key Trends 17

4.3.1 Despite an Increase in the Number of Musculoskeletal Tissue Donors, There is Still a Shortage of Bone Allografts in the Market 17

4.3.2 Orthobiologics Market is Facing Consolidation 18

4.3.3 Surgeries Involving Orthobiologic Material are Increasing Through Medical Tourism 18

4.4 Global Orthobiologics, Market Dynamics 19

4.4.1 Market Drivers 19

4.4.2 Market Restraints 23

5 Global Orthobiologics Market - Analysis By Segment 25

5.1 Bone Graft Substitutes Market, Global, Revenue ($m), Historic, 2003 - 2010 25

5.2 Bone Graft Substitutes Market, Global, Revenue ($m), Forecast, 2010 - 2017 26

5.2.1 Market Driver 27

5.2.2 Market Restraints 29

5.3 Viscosupplementation Market, Global, Revenue ($m), Historic, 2003 - 2010 32

5.4 Viscosupplementation Market, Global, Revenue ($m), Forecast, 2010 - 2017 33

5.4.1 Market Driver 34

5.4.2 Market Restraint 36

5.5 Bone Allografts Market, Global, Revenue ($m), Historic, 2003 - 2010 37

5.6 Bone Allografts Market, Global, Revenue ($m), Forecast, 2010 - 2017 38

5.6.1 Market Driver 39

5.6.2 Market Restraint 39

5.7 Bone Growth Stimulators Market, Global, Revenue ($m), Historic, 2003 - 2010 40

5.8 Bone Growth Stimulators Market, Global, Revenue ($m), Forecast, 2010 - 2017 41

5.8.1 Market Driver 42

5.8.2 Market Restraint 42

6 Global Orthobiologics Market - Analysis and Forecasts by Country 43

6.1 Orthobiologics Market, The US, Revenue ($m), Historic, 2003 - 2010 43

6.2 Orthobiologics Market, The US, Revenue ($m), Forecast, 2010 - 2017 44

6.3 Orthobiologics Market, Canada, Revenue ($m), Historic, 2003 - 2010 45

6.4 Orthobiologics Market, Canada, Revenue ($m), Forecast, 2010 - 2017 46

6.5 Orthobiologics Market, The UK, Revenue ($m), Historic, 2003 - 2010 47

6.6 Orthobiologics Market, The UK, Revenue ($m), Forecast, 2010 - 2017 48

6.7 Orthobiologics Market, Germany, Revenue ($m), Historic, 2003 - 2010 49

6.8 Orthobiologics Market, Germany, Revenue ($m), Forecast, 2010 - 2017 50

6.9 Orthobiologics Market, France, Revenue ($m), Historic, 2003 - 2010 51

6.10 Orthobiologics Market, France, Revenue ($m), Forecast, 2010 - 2017 52

6.11 Orthobiologics Market, Italy, Revenue ($m), Historic, 2003 - 2010 53

6.12 Orthobiologics Market, Italy, Revenue ($m), Forecast, 2010 - 2017 54

6.13 Orthobiologics Market, Spain, Revenue ($m), Historic, 2003 - 2010 55

6.14 Orthobiologics Market, Spain, Revenue ($m), Forecast, 2010 - 2017 56

6.15 Orthobiologics Market, Japan, Revenue ($m), Historic, 2003 - 2010 57

6.16 Orthobiologics Market, Japan, Revenue ($m), Forecast, 2010 - 2017 58

6.17 Orthobiologics Market, China, Revenue ($m), Historic, 2003 - 2010 60

6.18 Orthobiologics Market, China, Revenue ($m), Forecast, 2010 - 2017 61

6.19 Orthobiologics Market, India, Revenue ($m), Historic, 2003 - 2010 62

6.20 Orthobiologics Market, India, Revenue ($m), Forecast, 2010 - 2017 63

6.21 Orthobiologics Market, Australia, Revenue ($m), Historic, 2003 - 2010 64

6.22 Orthobiologics Market, Australia, Revenue ($m), Forecast, 2010 - 2017 65

6.23 Orthobiologics Market, Brazil, Revenue ($m), Historic, 2003 - 2010 66

6.24 Orthobiologics Market, Brazil, Revenue ($m), Forecast, 2010 - 2017 67

7 Global Orthobiologics Market - Competitive Assessment 68

7.1 Orthobiologics Market, Global, Key Company Share (%), 2010 68

7.2 Orthobiologics Market, Key Market Participants 69

7.2.1 Medtronic, Inc. 69

7.2.2 DePuy, Inc. 72

7.2.3 Genzyme Corporation 75

7.2.4 Synthes, Inc. 77

8 Global Orthobiologics Market - Pipeline Assessment 81

8.1 Orthobiologics, Pipeline Products, by Stage of Development, Global, 2011 81

8.2 Orthobiologic Pipeline Products, by Segment 81

8.2.1 Bone Allografts 81

8.2.2 Bone Graft Substitutes 85

8.2.3 Bone Growth Stimulators 91

8.2.4 Viscosupplementation 94

8.2.5 Other Orthobiologic Pipeline Products 95

9 Global Orthobiologics Market - Strategic Deals Analysis 99

9.1 Deals Overview, 2006 - 2011 99

9.2 Key Deals, Orthobiologics Market 100

9.2.1 Stryker to Acquire Orthovita 100

9.2.2 Johnson & Johnson Enters into an Agreement to Acquire Synthes 100

9.2.3 Sanofi-Aventis Completes Acquisition of Genzyme 100

9.2.4 Medtronic Completes Acquisition of Osteotech 101

9.2.5 Baxter International Completes Acquisition of ApaTech 101

10 Appendix 102

10.1 Market Definitions 103

10.1.1 Orthobiologics 103

10.2 Abbreviations (in alphabetical order) 104

10.3 Research Methodology 105

10.4 GlobalData Consulting 106

10.5 Contact Us 106

10.6 Disclaimer 107

1.1 List of Tables

Table 1: Orthobiologics Market, Global, Revenue ($bn), 2003 - 2010 15

Table 2: Orthobiologics Market, Global, Revenue ($bn), 2010 - 2017 16

Table 3: Number of Musculoskeletal Tissue Donors in the US, 2001 - 2007 17

Table 4: Cost Comparison of Orthopedic Procedures 18

Table 5: Studies Indicating Efficacy of Orthobiologic Products 19

Table 6: Prevalence of Arthritis and Arthritis-Attributable Activity Limitation Among Adults, US, 2003 - 2009 20

Table 7: Spinal Fusion Procedures Volumes (m), Global, 2006 - 2010 21

Table 8: Spinal Fusion Studies in Elderly Patients, 2006 - 2009 22

Table 9: Number of Orthopedic Surgeons in the US, 2002 - 2010 23

Table 10: Orthopedic Surgeons by Age Group, The US, 2010 24

Table 11: Bone Graft Substitutes Market, Global, Revenue ($m), 2003 - 2010 25

Table 12: Bone Graft Substitutes Market, Global, Revenue ($m), 2010 - 2017 26

Table 13: Bone Morphogenetic Proteins, Clinical Trials 27

Table 14: Synthetic Bone Graft Substitutes, Clinical Trials 28

Table 15: DBM, Clinical Trials 28

Table 16: Bone Graft Substitutes, Average Selling Price ($), the US, 2003-2010 29

Table 17: Viscosupplementation Market, Global, Revenue ($m), 2003 - 2010 32

Table 18: Viscosupplementation Market, Global, Revenue ($m), 2010 - 2017 33

Table 19: Studies Supporting Treatment of Ankle Osteoarthritis with Viscosupplements, 2006 - 2008 34

Table 20: Studies Supporting Treatment of Hip Osteoarthritis with Viscosupplements, 2006 - 2009 35

Table 21: Studies Supporting Treatment of Shoulder Osteoarthritis with Viscosupplements, 2008 - 2009 35

Table 22: Revenue ($m) and Average Selling Price ($), Viscosupplementation, The US, 2010 - 2017 36

Table 23: Bone Allografts, Global, Revenue ($m), 2003 - 2010 37

Table 24: Bone Allografts Market, Global, Revenue ($m), 2010 - 2017 38

Table 25: Bone Growth Stimulators Market, Global, Revenue ($m), 2003 - 2010 40

Table 26: Bone Growth Stimulators Market, Global, Revenue ($m), 2010 - 2017 41

Table 27: Number of Sports Related Injuries in the US (000s), 2007 - 2009 42

Table 28: Orthobiologics Market, The US, Revenue ($m), 2003 - 2010 43

Table 29: Orthobiologics Market, The US, Revenue ($m), 2010 - 2017 44

Table 30: Orthobiologics Market, Canada, Revenue ($m), 2003 - 2010 45

Table 31: Orthobiologics Market, Canada, Revenue ($m), 2010 - 2017 46

Table 32: Orthobiologics Market, The UK, Revenue ($m), 2003 - 2010 47

Table 33: Orthobiologics Market, The UK, Revenue ($m), 2010 - 2017 48

Table 34: Orthobiologics Market, Germany, Revenue ($m), 2003 - 2010 49

Table 35: Orthobiologics Market, Germany, Revenue ($m), 2010 - 2017 50

Table 36: Orthobiologics Market, France, Revenue ($m), 2003 - 2010 51

Table 37: Orthobiologics Market, France, Revenue ($m), 2010 - 2017 52

Table 38: Orthobiologics Market, Italy, Revenue ($m), 2003 - 2010 53

Table 39: Orthobiologics Market, Italy, Revenue ($m), 2010 - 2017 54

Table 40: Orthobiologics Market, Spain, Revenue ($m), 2003 - 2010 55

Table 41: Orthobiologics Market, Spain, Revenue ($m), 2010 - 2017 56

Table 42: Orthobiologics Market, Japan, Revenue ($m), 2003 - 2010 57

Table 43: Orthobiologics Market, Japan, Revenue ($m), 2010 - 2017 58

Table 44: Bone Graft Procedures in Japan, 1995 - 2004 59

Table 45: Orthobiologics Market, China, Revenue ($m), 2003 - 2010 60

Table 46: Orthobiologics Market, China, Revenue ($m), 2010 - 2017 61

Table 47: Orthobiologics Market, India, Revenue ($m), 2003 - 2010 62

Table 48: Orthobiologics Market, India, Revenue ($m), 2010 - 2017 63

Table 49: Orthobiologics Market, Australia, Revenue ($m), 2003 - 2010 64

Table 50: Orthobiologics Market, Australia, Revenue ($m), 2010 - 2017 65

Table 51: Orthobiologics Market, Brazil, Revenue ($m), 2003 - 2010 66

Table 52: Orthobiologics Market, Brazil, Revenue ($m), 2010 - 2017 67

Table 53: Orthobiologics Market, Global, Company Revenue ($m), 2010 68

Table 54: Key Products, Medtronic, Inc., 2011 69

Table 55: Key Products, DePuy, Inc., 2011 72

Table 56: Key Marketed Products, Genzyme Corporation, 2011 75

Table 57: Key Marketed Products, Synthes, Inc., 2011 77

Table 58: Orthobiologics, Pipeline by Stage, 2011 81

Table 59: Bone Allografts, Pipeline by Stage and Territory, 2011 81

Table 60: CR-Plug, Clinical Trial Details, 2011 82

Table 61: CR-Plug, Clinical Trial Details, 2011 83

Table 62: CR-Plug, Clinical Trial Details, 2011 84

Table 63: Bone Graft Substitutes, Pipeline by Stage and Territory, 2011 85

Table 64: AMPLEX Osteo-Promotive Bone Graft System, Clinical Trial Details, 2011 87

Table 65: Cerament Spine Support, Clinical Trial Details, 2011 89

Table 66: Amplify rhBMP-2, Clinical Trial Details, 2011 90

Table 67: Bone Growth Stimulators, Pipeline by Stage and Territory, 2011 91

Table 68: CartiStem, Clinical Trial Details, 2011 92

Table 69: Viscosupplementation, Pipeline by Stage and Territory, 2011 94

Table 70: Durolane, Clinical Trial Details, 2011 94

Table 71: Other Orthobiologic Products, Pipeline by Stage and Territory, 2011 95

Table 72: GelrinC, Clinical Trial Details, 2011 97

Table 73: Orthobiologics Market, Global, Key Deals Overview, 2006 - 2011* 99

1.2 List of Figures

Figure 1: Orthobiologics Market Segmentation 9

Figure 2: Applications of Orthobiologics 12

Figure 3: Orthobiologics Market, Global, Revenue ($bn), 2003 - 2010 15

Figure 4: Orthobiologics Market, Global, Revenue ($bn), 2010 - 2017 16

Figure 5: Number of Musculoskeletal Tissue Donors in the US, 2001 - 2007 17

Figure 6: Global Orthobiologics, Market Dynamics 19

Figure 7: Prevalence of Arthritis and Arthritis-Attributable Activity Limitation Among Adults, US, 2003 - 2009 20

Figure 8: Spinal Fusion Procedures Volumes (Millions), Global, 2006 - 2010 21

Figure 9: Orthopedic Surgeons by Age Group, The US, 2010 24

Figure 10: Bone Graft Substitutes Market, Global, Revenue ($m), 2003 - 2010 25

Figure 11: Bone Graft Substitutes Market, Global, Revenue ($m), 2010 - 2017 26

Figure 12: Viscosupplementation Market, Global, Revenue ($m), 2003 - 2010 32

Figure 13: Viscosupplementation Market, Global, Revenue ($m), 2010 - 2017 33

Figure 14: Revenue ($m) and Average Selling Price ($), Viscosupplementation, The US, 2010 - 2017 36

Figure 15: Bone Allografts, Global, Revenue ($m), 2003 - 2010 37

Figure 16: Bone Allografts Market, Global, Revenue ($m), 2010 - 2017 38

Figure 17: Bone Growth Stimulators Market, Global, Revenue ($m), 2003 - 2010 40

Figure 18: Bone Growth Stimulators Market, Global, Revenue ($m), 2010 - 2017 41

Figure 19: Number of Sports Related Injuries in the US (000s), 2007 - 2009 42

Figure 20: Orthobiologics Market, The US, Revenue ($m), 2003 - 2010 43

Figure 21: Orthobiologics Market, The US, Revenue ($m), 2010 - 2017 44

Figure 22: Orthobiologics Market, Canada, Revenue ($m), 2003 - 2010 45

Figure 23: Orthobiologics Market, Canada, Revenue ($m), 2010 - 2017 46

Figure 24: Orthobiologics Market, The UK, Revenue ($m), 2003 - 2010 47

Figure 25: Orthobiologics Market, The UK, Revenue ($m), 2010 - 2017 48

Figure 26: Orthobiologics Market, Germany, Revenue ($m), 2003 - 2010 49

Figure 27: Orthobiologics Market, Germany, Revenue ($m), 2010 - 2017 50

Figure 28: Orthobiologics Market, France, Revenue ($m), 2003 - 2010 51

Figure 29: Orthobiologics Market, France, Revenue ($m), 2010 - 2017 52

Figure 30: Orthobiologics Market, Italy, Revenue ($m), 2003 - 2010 53

Figure 31: Orthobiologics Market, Italy, Revenue ($m), 2010 - 2017 54

Figure 32: Orthobiologics Market, Spain, Revenue ($m), 2003 - 2010 55

Figure 33: Orthobiologics Market, Spain, Revenue ($m), 2010 - 2017 56

Figure 34: Orthobiologics Market, Japan, Revenue ($m), 2003 - 2010 57

Figure 35: Orthobiologics Market, Japan, Revenue ($m), 2010 - 2017 58

Figure 36: Orthobiologics Market, China, Revenue ($m), 2003 - 2010 60

Figure 37: Orthobiologics Market, China, Revenue ($m), 2010 - 2017 61

Figure 38: Orthobiologics Market, India, Revenue ($m), 2003 - 2010 62

Figure 39: Orthobiologics Market, India, Revenue ($m), 2010 - 2017 63

Figure 40: Orthobiologics Market, Australia, Revenue ($m), 2003 - 2010 64

Figure 41: Orthobiologics Market, Australia, Revenue ($m), 2010 - 2017 65

Figure 42: Orthobiologics Market, Brazil, Revenue ($m), 2003 - 2010 66

Figure 43: Orthobiologics Market, Brazil, Revenue ($m), 2010 - 2017 67

Figure 44: Orthobiologics Market, Global, Key Company Share (%), 2010 68

Figure 45: SWOT Analysis, Medtronic, Inc. 69

Figure 46: SWOT Analysis, Depuy Inc. 73

Figure 47: SWOT Analysis, Genzyme Corporation 75

Figure 48: SWOT Analysis, Synthes Inc. 78

Figure 49: Orthobiologics, Pipeline by Stage, 2011 81

Figure 50: Orthobiologics Market, Global, Key Deals Overview, 2006 - 2011* 99

Companies mentioned

Medtronic, Inc.

DePuy, Inc.

Genzyme Corporation

Synthes, Inc.

To order this report:

Biomaterial Industry: Orthobiologics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Biomaterial Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com